Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study
Clinical trial NCT02861859 · COMPLETED
Trial details
- NCT number
- NCT02861859
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2019-12-23
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.